Evidence map›Paper›PMID 28407967›Full record

ArticleFood chemistry2017

Molecular characterization of an unauthorized genetically modified Bacillus subtilis production strain identified in a vitamin B

Valentina Paracchini, Mauro Petrillo, Ralf Reiting, Alexandre Angers-Loustau, Daniela Wahler, Andrea Stolz, Birgit Schönig, Anastasia Matthies, Joachim Bendiek, Dominik M Meinel and 5 more

Abstract read
In one paragraph

Article in Food chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Detection ofFood chemistry. Molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Metabolic Engineering ofMicroorganisms · 2023
    Review
  9. Retrospective surveillance of viableFrontiers in microbiology · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Production of Vitamin B2 (Riboflavin) by Microorganisms: An Overview.Frontiers in bioengineering and biotechnology · 2020
    Review
  20. EFSA statement on the risk posed to humans by a vitamin BEFSA journal. European Food Safety Authority · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Valentina ParacchiniEuropean Commission, Joint Research Centre, Ispra, Italy.
Mauro PetrilloEuropean Commission, Joint Research Centre, Ispra, Italy.
Ralf ReitingHessian State Laboratory Kassel (LHL), Kassel, Germany.
Alexandre Angers-LoustauEuropean Commission, Joint Research Centre, Ispra, Italy.
Daniela WahlerFederal Office of Consumer Protection and Food Safety (BVL), Genetic Engineering Department, Berlin, Germany.
Andrea StolzFederal Office of Consumer Protection and Food Safety (BVL), Genetic Engineering Department, Berlin, Germany.
Birgit SchönigFederal Office of Consumer Protection and Food Safety (BVL), Genetic Engineering Department, Berlin, Germany.
Anastasia MatthiesFederal Office of Consumer Protection and Food Safety (BVL), Genetic Engineering Department, Berlin, Germany.
Joachim BendiekFederal Office of Consumer Protection and Food Safety (BVL), Genetic Engineering Department, Berlin, Germany.
Dominik M MeinelBavarian Health and Food Safety Authority (LGL), Oberschleissheim, Germany.
Sven PecoraroBavarian Health and Food Safety Authority (LGL), Oberschleissheim, Germany.
Ulrich BuschBavarian Health and Food Safety Authority (LGL), Oberschleissheim, Germany.
Alex PatakEuropean Commission, Joint Research Centre, Ispra, Italy.
Joachim KreysaEuropean Commission, Joint Research Centre, Ispra, Italy.
Lutz GrohmannFederal Office of Consumer Protection and Food Safety (BVL), Genetic Engineering Department, Berlin, Germany. Electronic address: lutz.grohmann@bvl.bund.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many food and feed additives result from fermentation of genetically modified (GM) microorganisms. For vitamin B2 (riboflavin), GM Bacillus subtilis production strains have been developed and are often used. The presence of neither the GM strain nor its recombinant DNA is allowed for fermentation products placed on the EU market as food or feed additive. A vitamin B

Indexed as

Bacillus subtilisOrganisms, Genetically ModifiedPlants, Genetically ModifiedReal-Time Polymerase Chain ReactionRiboflavinRiboflavinBacillus subtilisDetectionFeed additivesGenetically modified microorganisms (GMM)Genetically modified organism (GMO)Next generation sequencing (NGS)Polymerase chain reaction (PCR)Vitamin B(2)

Identifiers

PMID28407967
PMCPMC5399532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.